CC 5 weeks out, update on company(more time) possible IND delay, immediate trial in question......... any plans while company is generating revenue sufficient to support operation is ok but no revenue and no significant funding is a problem......... Where should this company be today if only 50% of the fluff would have been successful..........
Time for additional dilution........
(1)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links